HCPLive Network

Evidence for Strong Genetic Selection Against Some Psychiatric Disorders

 
FRIDAY, Jan. 4 (HealthDay News) -- Different evolutionary mechanisms likely support the persistence of various psychiatric disorders, according to a study published in the January issue of JAMA Psychiatry.

Robert A. Power, from King's College London, and colleagues measured the fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse versus their unaffected siblings and the general population in order to assess the level of selection on causal genetic variants. Data were obtained from the Swedish Multi-Generation Register and the Swedish Hospital Discharge Register for 2.3 million individuals in the 1950 to 1970 birth cohort.

The researchers found that affected patients had significantly fewer children (fertility rate range from 0.23 to 0.93), with the exception of women with depression. The reduction in fecundity was greater among men than women. Sisters of patients with schizophrenia and bipolar disorder had significantly increased fecundity, while brothers of patients with schizophrenia and autism showed significantly lower fecundity. Fecundity was significantly increased among all siblings of patients with depression and substance abuse.

Our results suggest that strong selection exists against schizophrenia, autism, and anorexia nervosa and that these variants may be maintained by new mutations or an as-yet unknown mechanism," the authors write. "Vulnerability to depression, and perhaps substance abuse, may be preserved by balancing selection, suggesting the involvement of common genetic variants in ways that depend on other genes and on environment."

One author disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Success is a journey. Having the proper accounting methods established early on in your career will make the journey more enjoyable, although never without challenges.
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
More Reading